• Blog
  • Protein Engineering Market Analysis & Forecast | 2022-2028

    Protein Engineering Market Analysis & Forecast | 2022-2028

    Protein Engineering Market Analysis & Forecast | 2022-2028
    Report code - SRAM468 Delivery - 2 Weeks
    Get Free Sample |
    Protein Engineering Market Size, Share, Trend, Forecast, Industry Analysis & Growth Op See more...

    Market Insights

    The protein engineering market size was valued at USD 2.6 billion in 2021 and is likely to grow at a CAGR of 12.49% during 2022-2028 to reach USD 5.96 billion in 2028

    Protein-Engineering-Market-Insights

    Want to know more about the market scope: 

    What is protein engineering?

    Protein engineering is the process of altering a protein sequence to attain the desired result such as increased stability to the temperature, organic solvents, and/or extremes of pH or a change in the substrate capacity. 

    Market Drivers

    The major factors that are driving the market, are-

    • Increasing investments in synthetic biology,
    • mounting focus on protein-based drug development by biotechnology and pharmaceutical companies. 

    Protein-Engineering-Market-Snapshot

    Want to have a closer look at this report, Download a free sample here

    Segment Analysis

    By Products & Services Type

    Based on the products & services type, the market is segmented as instruments, consumables, and software & services. The instrument segment held the largest share of the market in 2021 and is expected to remain dominant during the forecast period. Technological advancements and the high price of mass spectroscopy and crystallography instruments are the major factors leading to the dominance of the instrument segment.

    By Protein Type

    Based on the protein type, the market is segmented as monoclonal antibodies, erythropoietin, interferons, vaccines, colony-stimulating factors, growth hormones, coagulation factors, and others. The monoclonal antibodies segment dominated the market in 2021 and is expected to maintain its position during the forecast period. Increasing demand for monoclonal antibodies for the treatment of cancer, neurological diseases, and infectious diseases is the major factor behind its dominance.

    Regional Insights

    In terms of regions, North America is estimated to be the largest market during the forecast period. The presence of well-established CROs, increasing investment in R&D, and the availability of the latest techniques and instruments for drug discovery research are the major factors behind the dominance of the North American market.

    Asia-Pacific is expected to be the fastest-growing market during the forecast period. Advancements in genomics and proteomics research and government initiatives and funding for protein-based drug research in key countries are the major factors behind the extraordinary growth of the region’s market.

    Protein-Engineering-Market-Regional-Analysis

    Want to know which region offers the best growth opportunities then, 

    Market Scope & Segmentation

    This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

    The market is segmented into the following categories. 

    By Products & Services Type

    • Instruments
    • Consumables
    • Software & Services

    By Protein Type

    • Monoclonal Antibodies 
    • Erythropoietin
    • Interferons
    • Vaccines
    • Colony-stimulating Factors
    • Growth Hormones
    • Coagulation Factors
    • Others

    By Technology Type

    • Rational Protein Design
    • Irrational Protein Design

    By End-User Type

    • Biopharmaceutical Companies
    • Contract Research Organizations
    • Academic Research Institutes

    By Region

    • North America (Country Analysis: the USA, Canada, and Mexico) 
    • Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe)
    • Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
    • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

    Protein-Engineering-Market-Segmentation

    Know more about various segments of this report. 

    Top Players

    Some of the top players in the market are:

    • Bio-Rad Laboratories, Inc.,
    • Thermo Fisher Scientific, Inc.,
    • Bruker Corporation,
    • Agilent Technologies, Inc.,
    • Waters Corporation,
    • Danaher Corporation,
    • Codexis, Inc.,
    • New England Biolabs, Inc.,
    • PerkinElmer,
    • Innovagen AB,
    • GE Healthcare,
    • CUSABIO TECHNOLOGY LLC,
    • Promega Corporation,
    • Merck KGaA,
    • GenScript Biotech Corporation,
    • Takara Bio, Inc.,
    • Enantis S.R.O.,
    • InvivoGen,
    • Pace Analytical,
    • Aspira Chemical,
    • Zymeworks, Inc.,
    • Abzena, Ltd.,
    • PhyNexus, Inc.,
    • ProteoGenix,
    • Creative Biolabs.

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

    We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

    • Market structure: Overview, industry life cycle analysis, supply chain analysis
    • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
    • Market trend and forecast analysis
    • Market segment trend and forecast
    • Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
    • Attractive market segments and associated growth opportunities
    • Emerging trends
    • Strategic growth opportunities for the existing and new players
    • Key success factors

    Report Features

    Market Segmentation

    5

    Regions Covered

    4

    Countries/Sub-Regions Covered

    15

    No. of Figures & Tables

    >150

    Company Profiles

    10

    Report Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players)
    • SWOT analysis of key players (up to 3 players)

    Market Segmentation

    • Current market segmentation of any one of the protein types by application type.

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com

    Frequently Asked Questions (FAQs)

    The market was valued at USD 2.6 billion in 2021.

    The market is likely to reach USD 5.96 Billion in 2028.

    The projected CAGR for the market will be 12.49%.

    Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Bruker Corporation, Agilent Technologies, Inc., Waters Corporation, Danaher Corporation, Codexis, Inc., New England Biolabs, Inc., PerkinElmer, Innovagen AB, GE Healthcare, CUSABIO TECHNOLOGY LLC, Promega Corporation, Merck KGaA, GenScript Biotech Corporation, Takara Bio, Inc., Enantis S.R.O., InvivoGen, Pace Analytical, Aspira Chemical, Zymeworks, Inc., Abzena, Ltd., PhyNexus, Inc., ProteoGenix, and Creative Biolabs.

    Protein engineering is the process of altering a protein sequence to attain the desired result such as increased stability to the temperature, organic solvents, and/or extremes of pH or a change in the substrate capacity.

    North America is expected to be the leading region in the market during the next five years.

    The monoclonal antibodies and instrument segment are expected to be the most dominant segment in the market.

    Some of the major factors driving the market are Increasing investments in synthetic biology and mounting focus on protein-based drug development by biotechnology and pharmaceutical companies.